As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to reveal that inhaled corticosteroid therapy combined with a
short-acting beta2- agonist given on a symptom driven basis is as effective as traditional
asthma therapy.
Thus, three advantages will be achieved:
1. better compliance with treatment since patients will most likely have to administer the
treatment less frequently,
2. maximum pharmacological effect with the least amount of drug and
3. less economic burden on health care providers.